Volume 3, Issue 4 (November 2024)
Health Science Monitor 2024, 3(4): 358-367 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseinzadeh S, Davar S. Control of glycaemia and its related factors in patients with type 2 diabetes, north of Iran: generalized linear mixed models and prevalence of overdispersion in patients. Health Science Monitor 2024; 3 (4) :358-367
URL: http://hsm.umsu.ac.ir/article-1-182-en.html
URL: http://hsm.umsu.ac.ir/article-1-182-en.html
Department of Epidemiology Biostatistics, Urmia University of Medical Sciences, Urmia, Iran
Abstract: (666 Views)
Background & Aims: Glycemic control is very important to prevent or suspend complications in patients with type 2 diabetes (PT2D). The aim of this study was to investigate the status of glycemic control and its related factors in patients with type 2 diabetes (PT2D) based on HbA1c, fasting blood glucose, and non-fasting blood glucose levels in Golestan Province, Northern Iran.
Materials & Methods: The study employed a retrospective cohort design, collecting data longitudinally and retrospectively from 500 patients with type 2 diabetes (PT2D) who were referred to health centers in Golestan Province between 2013 and 2016 (every three months). The study focused on hbA1c, fasting blood glucose (FBG), and non-fasting blood glucose (NFBG) levels, which were recorded as binary data (1 = abnormal; if the value exceeded its cut point), indicating a lack of control over these markers. The Index of Glycemic Control (IGC) was calculated for each patient, with an IGC of 3 indicating inadequate glycemic control. Related factors were analyzed using a generalized linear mixed model with a beta-binomial distribution.
Results: The results indicated that 93% of patients had an Index of Glycemic Control (IGC) equal to 3 in the first year, and this percentage decreased to 60.7% by the third year. The downward trend in IGC was gradual over the three years. Factors contributing to poor glycemic control included younger age, shorter duration of diabetes care, elevated blood lipid levels, high blood pressure, insulin therapy, and overweight or obesity as indicated by BMI.
Conclusion: The results obtained from the samples in Golestan Province indicate inadequate blood glucose control and poor quality of care. It is essential to implement more intensive diabetes management strategies within national healthcare plans.
Materials & Methods: The study employed a retrospective cohort design, collecting data longitudinally and retrospectively from 500 patients with type 2 diabetes (PT2D) who were referred to health centers in Golestan Province between 2013 and 2016 (every three months). The study focused on hbA1c, fasting blood glucose (FBG), and non-fasting blood glucose (NFBG) levels, which were recorded as binary data (1 = abnormal; if the value exceeded its cut point), indicating a lack of control over these markers. The Index of Glycemic Control (IGC) was calculated for each patient, with an IGC of 3 indicating inadequate glycemic control. Related factors were analyzed using a generalized linear mixed model with a beta-binomial distribution.
Results: The results indicated that 93% of patients had an Index of Glycemic Control (IGC) equal to 3 in the first year, and this percentage decreased to 60.7% by the third year. The downward trend in IGC was gradual over the three years. Factors contributing to poor glycemic control included younger age, shorter duration of diabetes care, elevated blood lipid levels, high blood pressure, insulin therapy, and overweight or obesity as indicated by BMI.
Conclusion: The results obtained from the samples in Golestan Province indicate inadequate blood glucose control and poor quality of care. It is essential to implement more intensive diabetes management strategies within national healthcare plans.
Keywords: Blood pressure, BMI, Fasting blood glucose, Generalized Linear Mixed Models, HbA1c, Long-Term Care, Overdispersion
Type of Study: Research |
Subject:
Health promotion and disease prevention
Received: 2024/06/11 | Accepted: 2024/10/27 | Published: 2024/11/20
Received: 2024/06/11 | Accepted: 2024/10/27 | Published: 2024/11/20
References
1. Simão CCAL, Costa MB, Colugnati FAB, de Paula EA, Vanelli CP, de Paula RB. Quality of Care of Patients with Diabetes in Primary Health Services in Southeast Brazil. Journal of environmental and public health (J Environ Public Health ). 2017;2017(Article ID 1709807):7 pages. [DOI] [PMID] [PMCID]
2. Hacker KA, Briss PA, Richardson L, Wright J, Petersen R. Peer reviewed: COVID-19 and chronic disease: the impact now and in the future. Preventing chronic disease. 2021;18. [DOI] [PMID] [PMCID]
3. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet. 2009;374(9702):1677-86. [DOI] [PMID]
4. Lind M, Tuomilehto J, Uusitupa M, Nerman O, Eriksson J, Ilanne-Parikka P, et al. The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. PLoS One. 2014;9(10):e109506. [DOI] [PMID] [PMCID]
5. Bell RA, Arcury TA, Snively BM, Smith SL, Stafford JM, Dohanish R, et al. Diabetes foot self-care practices in a rural, triethnic population. The diabetes educator. 2005;31(1):75-83. [DOI] [PMID] [PMCID]
6. Naghavi M. A Study on Burden of Disease, Accidents, and Risk Factors in the Islamic Republic of Iran. Tehran: Ministry of Health and Medical Education. 2008. [URL]
7. HbA M. Amputation Prevention Initiative in South India. [Google Scholar]
8. Najjar S, Almutairi AF, Massoud R, Al-Surimi K, Boghdadly S. Assessing the Feasibility and Effects of Introducing the USA National Surgical Quality Improvement Program on Clinical Outcomes and Cost in Saudi Arabia: An Observational Study. Global Journal on Quality and Safety in Healthcare. 2020;3(1):14-21. [DOI] [PMID] [PMCID]
9. Ribeiro SP, Cavalcanti MdLT. Primary Health Care and Coordination of Care: device to increase access and improve quality. Ciencia & saude coletiva. 2020;25:1799-808. [Google Scholar]
10. Emire MS, Zewudie BT, Tarekegn TT, GebreEyesus FA, Amlak BT, Mengist ST, et al. Self-care practice and its associated factors among diabetic patients attending public hospitals in Gurage zone southwest, Ethiopia. Plos one. 2022;17(9):e0271680. [DOI] [PMID] [PMCID]
11. Association AD. Introduction: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021;45(Supplement_1):S1-S2. [DOI] [PMID]
12. Flores-Hernández S, Saturno-Hernandez PJ, Reyes-Morales H, Barrientos-Gutierrez T, Villalpando S, Hernandez-Avila M. Quality of diabetes care: the challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012). PloS one. 2015;10(7):e0133958. [DOI] [PMID] [PMCID]
13. Yekta Z, Pourali R, Aghassi MR, Ashragh N, Ravanyar L, Pour MYR. Assessment of self-care practice and its associated factors among diabetic patients in urban area of Urmia, northwest of Iran. Journal of research in health sciences. 2023;11(1):33-8. [Google Scholar]
14. Yousefzadeh G, Shokoohi M, Najafipour H. Inadequate control of diabetes and metabolic indices among diabetic patients: A population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS). International Journal of Health Policy and Management. 2015;4(5):271. [DOI] [PMID] [PMCID]
15. Delavari A, Alikhani S, Nili S, Birjandi RH, Birjandi F. Quality of care of diabetes mellitus type II patients in Iran. 2009. [Google Scholar]
16. Ghazanfari Z, Niknami S, Ghofranipour F, Larijani B, Agha-Alinejad H, Montazeri A. Determinants of glycemic control in female diabetic patients: a study from Iran. Lipids in health and disease. 2010;9:1-5. [DOI] [PMID] [PMCID]
17. Chuang LM, Tsai S, Huang B, Tai T. The status of diabetes control in Asia-a cross‐sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabetic medicine. 2002;19(12):978-85. [DOI] [PMID]
18. Fox KM, Bolinder B, Chen J, Kumar S. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clinical therapeutics. 2006;28(3):388-95. [DOI] [PMID]
19. Al Balushi KA, Al-Haddabi M, Al-Zakwani I, Al Za'abi M. Glycemic control among patients with type 2 diabetes at a primary health care center in Oman. Primary care diabetes. 2014;8(3):239-43. [DOI] [PMID]
20. Kim C, Sohn J-H, Jang MU, Kim S-H, Choi M-G, Ryu O-H, et al. Association between visit-to-visit glucose variability and cognitive function in aged type 2 diabetic patients: a cross-sectional study. PLOS one. 2015;10(7):e0132118. [DOI] [PMID] []
21. Delavari A, Mahdavi A, Norouzinegad A, Yarahmadi S. Country Disease Prevention and Control Program. Ministry of Health and Medical Education, Tehran, Iran: Seda Distribution Center. 2005. [URL]
22. Babaniamansour S, Aliniagerdroudbari E, Niroomand M. Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study. Journal of Diabetes & Metabolic Disorders. 2020;19:933-40. [DOI] [PMID] [PMCID]
23. Kayar Y, Ilhan A, Kayar NB, Unver N, Coban G, Ekinci I, et al. Relationship between the poor glycemic control and risk factors, life style and complications. Biomed Res. 2017;28(4):1581-6. [Google Scholar]
24. Li J, Chattopadhyay K, Xu M, Chen Y, Hu F, Chu J, et al. Glycaemic control in type 2 diabetes patients and its predictors: a retrospective database study at a tertiary care diabetes centre in Ningbo, China. BMJ open. 2018;8(3):e019697. [DOI] [PMID] [PMCID]
25. Eid M, Mafauzy M, Faridah A. Glycaemic control of type 2 diabetic patients on follow up at Hospital Universiti Sains Malaysia. The Malaysian journal of medical sciences: MJMS. 2003;10(2):40. [PMID] [PMCID]
26. Ashur ST, Shah SA, Bosseri S, Fah TS, Shamsuddin K. Glycaemic control status among type 2 diabetic patients and the role of their diabetes coping behaviours: a clinic-based study in Tripoli, Libya. Libyan Journal of Medicine. 2016;11(1). [DOI] [PMID] [PMCID]
27. Gerstein HC, Miller ME, Byington RP, Goff DJ, Bigger JT, Buse JB, et al. Action to Control Cardiovascular Risk in Diabetes Study, Group. Effects of intensive glucose lowering in type. 2008;2:2545-59. [DOI] [PMCID]
28. Tekalegn Y, Addissie A, Kebede T, Ayele W. Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. PloS one. 2018;13(3):e0193442. [DOI] [PMID] [PMCID]
29. Li N, Fu J, Koonen DP, Kuivenhoven JA, Snieder H, Hofker MH. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis. 2014;233(1):130-8. [DOI] [PMID]
30. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Supplement_1):S145-S57. [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
